Log in
Enquire now
‌

US Patent 7888317 Glucagon-like peptide-2 and its therapeutic use

Patent 7888317 was granted and assigned to Nps Pharmaceuticals on February, 2011 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Nps Pharmaceuticals
Nps Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
78883170
Patent Inventor Names
Daniel J. Drucker0
Date of Patent
February 15, 2011
0
Patent Application Number
113255270
Date Filed
January 5, 2006
0
Patent Citations Received
‌
US Patent 11867701 Methods for prognosing crohn's disease comprising human defensin 5 (HD5)
0
Patent Primary Examiner
‌
Andrew D. Kosar
0
Patent abstract

Glucagon-like peptide 2, a product of glucagon gene expression, and analogs of glucagon-like peptide 2, have been identified as gastrointestinal tissue growth factors. Their effects on the growth of small bowel and pancreatic islets are described. Their formulation as a pharmaceutical, and their therapeutic use in treating disorders of the bowel, are described.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7888317 Glucagon-like peptide-2 and its therapeutic use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.